Racial Differences in Elevated C‐Reactive Protein Among US Older Adults

Abstract

OBJECTIVES: To investigate racial differences in elevated C-reactive protein (CRP) and the potential factors contributing to these differences in US older men and women. DESIGN: Nationally representative cohort study. SETTING: Health and Retirement Study, 2006 to 2014. PARTICIPANTS: Noninstitutionalized non-Hispanic black and white older adults living in the United States (n = 13 517). MEASUREMENTS: CRP was categorized as elevated (>3.0 mg/L) and nonelevated (≤3.0 mg/L) as the primary outcome. Measures for demographic background, socioeconomic status, psychosocial factors, health behaviors, and physiological health were examined as potential factors contributing to race differences in elevated CRP. RESULTS: Median CRP levels (interquartile range) were 1.67 (3.03) mg/L in whites and 2.62 (4.95) mg/L in blacks. Results from random effects logistic regression models showed that blacks had significantly greater odds of elevated CRP than whites (odds ratio = 2.58; 95% confidence interval [CI] = 2.20-3.02). Results also showed that racial difference in elevated CRP varied significantly by sex (predicted probability [PP] [white men] = 0.28 [95% CI = 0.27-0.30]; PP [black men] = 0.38 [95% CI = 0.35-0.41]; PP [white women] = 0.35 [95% CI = 0.34-0.36]; PP [black women] = 0.49 [95% CI = 0.47-0.52]) and remained significant after risk adjustment. In men, the racial differences in elevated CRP were attributable to a combination of socioeconomic (12.3%) and behavioral (16.5%) factors. In women, the racial differences in elevated CRP were primarily attributable to physiological factors (40.0%). CONCLUSION: In the US older adult population, blacks were significantly more likely to have elevated CRP than whites; and the factors contributing to these differences varied in men and women. J Am Geriatr Soc 68:362-369, 2020.

Impact of radiotherapy-induced inflammatory responses on progression-free survival in a tri-racial/ethnic breast cancer population

“…We also observed that a higher proportion of Black/AA patients had CRP ≥5.1 mg/L at post-RT (58%). This is consistent with the previous ndings that higher CRP levels were reported in Black/AA patients compared to whites, Chinese, or Japanese [35,36]. Multiple genetic and environmental factors may contribute to racial/ethnic differences in CRP levels.…”

Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study

“…A recent review posited that observed racial and ethnic differences in COVID-19 outcomes may arise from a differential inflammatory response between groups, driven by underlying differences in chronic inflammation from different burdens of co-morbidity, socio-economic factors, genetic factors, and psychologic stressors 25 . Differences in chronic inflammation as measured by CRP levels have been previously described, with several studies finding that Black patients have higher median CRP levels than White patients, though these differences were heavily attenuated after accounting for differences in comorbidities and psychosocial factors 26 , 27 . Similarly, after adjusting for cardiovascular and COVID-19 risk factors, Black race compared to non-Black was associated with relatively lower levels of CRP and suPAR, reflecting perhaps an attenuated inflammatory response to SARS-CoV-2 infection and leading to similar survival rates compared to non-Black patients despite their significantly higher burden of co-morbidities.…”

How social/environmental determinants and inflammation affect salivary telomere length among middle-older adults in the health and retirement study

“…As social support is an important mediator in the literature, and to ensure the role of positive social support was truly not important in explaining TL, we re-screened our final models of demographic and health variables, but found further evidence of social support being a confounder, so those results are not reported. Models 2, 3, 6 and 7 also add categorical measures of hs-CRP (mg/dL), the only inflammatory biomarker available from the same year of data when TL was collected: a binary measure of high hs-CRP (≤ 3 vs. > 3 and < 10 44 ) in Models 2 and 6, and a tri-level measure of hs-CRP (< 1, 1–3, > 3 and < 10 17 ) in Models 3 and 7.…”